Monomeric and dimeric gold(I) complexes as anticancer agents. The gold(I) complexes are coordinated to mixed ligands: one phosphine-based ligand that may be monodentate or bidentate and at least one dithiocarbamate-based ligand that is monodentate. Pharmaceutical compositions incorporating the gold(I) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis are also provided.
单聚和双聚
金(I)配合物作为抗癌剂。
金(I)配合物与混合
配体配位:一个基于膦的
配体,可能是一齿或二齿,以及至少一个基于二
硫代
氨基甲酸盐的一齿
配体。还提供了含有
金(I)配合物的制药组合物、合成方法、治疗癌症的方法、抑制癌细胞增殖的方法和诱导癌细胞凋亡的方法。